| Star Nwamaka Opara, | |
|
132 Evergreen Rd, Edison, NJ 08837-2484 | |
| (732) 452-4142 | |
| Not Available |
| Full Name | Star Nwamaka Opara |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 132 Evergreen Rd, Edison, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154086270 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 26NR1351800 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Star Nwamaka Opara, 930 Washington Ave, 132 Evergreen Road, Linden, NJ 07036-2950 Ph: () - | Star Nwamaka Opara, 132 Evergreen Rd, Edison, NJ 08837-2484 Ph: (732) 452-4142 |
News Archive
Following a recent spate of measles cases being reported in a number of Australian states, NPS MedicineWise is reminding parents to check whether their children's immunisations are up to date before they head back to school next week.
HIV/AIDS program grants made by U.S.-based foundations totaled $618 billion in 2008, an 11 percent increase from the previous year, according to a new report by Funders Concerned About AIDS, the Chronicle of Philanthropy reports. The Bill & Melinda Gates Foundation accounted for the majority of the grants, and when it was "excluded, foundation giving [for HIV/AIDS] actually declined 3 percent compared to 2007."
Squirting a simple saline solution into the nose twice a day could alleviate chronic nosebleeds just as effectively as spraying with any one of three different medications, reports a study published online in the Journal of the American Medical Association on Sept. 6.
Arena Pharmaceuticals, Inc. and Eisai Inc. reported today that top-line results from the one-year lorcaserin BLOOM-DM trial demonstrate statistically significant weight loss in obese and overweight patients with type 2 diabetes. In this trial, lorcaserin met all three co-primary efficacy endpoints. In addition, as described below, lorcaserin patients taking lorcaserin 10 mg twice daily (BID) achieved statistically significant improvements in multiple secondary endpoints, including HbA1c, as compared to patients randomized to placebo.
For the first time, the U.S. Food and Drug Administration has provided draft guidance clarifying how benefit-risk determinations are made during premarket review of certain medical devices.
› Verified 5 days ago
Merari Singh, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 65 James St, Edison, NJ 08820 Phone: 732-321-7000 | |
Mrs. Heidi F. Jimenez, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 7 Quaker St, Edison, NJ 08820 Phone: 908-756-8018 | |
Mrs. Katelynn Onulak, RN, MSN, APN-A Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 65 James St, Edison, NJ 08820 Phone: 732-943-6674 | |
Halina Debiak, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 132 Evergreen Rd, Edison, NJ 08837 Phone: 732-452-4100 | |
Mrs. Erlinda Torio Coronel-liggayu, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 41 Tower Rd, Edison, NJ 08820 Phone: 646-267-2291 | |
Mrs. Nicole A Kim, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 132 Evergreen Rd, Edison, NJ 08837 Phone: 732-452-4100 |